Metastatic Bladder Urothelial Carcinoma Masquerading as Myositis

被引:0
|
作者
Dilli, Christopher [1 ]
Mi, William [1 ]
Guzman, Miguel A. [1 ]
机构
[1] St Louis Univ, Dept Pathol, St Louis, MO USA
关键词
Metastatic urothelial carcinoma; Metastatic transitional cell carcinoma; Myositis; Skeletal muscle metastasis; TRANSITIONAL-CELL CARCINOMA; SKELETAL-MUSCLE METASTASIS; URINARY-BLADDER; PSOAS ABSCESS; CANCER; OUTCOMES;
D O I
10.14740/jmc4236
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Skeletal muscle metastases are uncommon, and metastases of urothelial carcinoma to the skeletal muscle are particularly rare. The most common presentation of skeletal muscle metastases is a focal mass, but their clinical and radiographic findings can be diverse. We present an unusual case of a 71-year-old male without prior known history of malignancy who presented with skeletal muscle pain with imaging most consistent with an inflammatory or infectious process but was ultimately determined to be metastatic urothelial carcinoma from the bladder. This case demonstrates the need to keep an expanded differential for muscular pain, particularly when initial treatments are ineffective.
引用
下载
收藏
页码:130 / 135
页数:6
相关论文
共 50 条
  • [31] Beyond first-line systemic treatment for metastatic urothelial carcinoma of the bladder
    E. El Rassy
    T. Assi
    Z. Bakouny
    N. Pavlidis
    J. Kattan
    Clinical and Translational Oncology, 2019, 21 : 280 - 288
  • [32] The effect of radical cystectomy on survival in patients with metastatic urothelial carcinoma of the urinary bladder
    Luzzago, Stefano
    Palumbo, Carlotta
    Rosiello, Giuseppe
    Pecoraro, Angela
    Deuker, Marina
    Tian, Zhe
    Shariat, Shahrokh F.
    Saad, Fred
    de Cobelli, Ottavio
    Karakiewicz, Pierre I.
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (07) : 1266 - 1275
  • [33] The Efficacy and Toxicity of Gemcitabine and Cisplatin Chemotherapy in Advanced/Metastatic Bladder Urothelial Carcinoma
    Gunlusoy, B.
    Arslan, M.
    Vardar, E.
    Degirmenci, T.
    Kara, C.
    Ceylan, Y.
    Kozacioglu, Z.
    ACTAS UROLOGICAS ESPANOLAS, 2012, 36 (09): : 515 - 520
  • [34] Beyond first-line systemic treatment for metastatic urothelial carcinoma of the bladder
    El Rassy, E.
    Assi, T.
    Bakouny, Z.
    Pavlidis, N.
    Kattan, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (03): : 280 - 288
  • [35] Can the success with immunotherapy in metastatic urothelial bladder carcinoma be replicated in the neoadjuvant setting?
    Aoun, Fouad
    Mjaess, Georges
    Nemr, Elie
    Albisinni, Simone
    Roumeguere, Thierry
    IMMUNOTHERAPY, 2020, 12 (17) : 1209 - 1212
  • [36] Urothelial Carcinoma In Situ of the Bladder
    Humphrey, Peter A.
    JOURNAL OF UROLOGY, 2012, 187 (03): : 1057 - 1058
  • [37] Plasmacytoid urothelial carcinoma of the bladder
    Qin, Meihua
    Wang, Gangping
    Sun, Yanqing
    He, Qun
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2014, 57 (02) : 320 - 322
  • [38] Atezolizumab in urothelial bladder carcinoma
    Hamilou, Zineb
    Lavaud, Pernelle
    Loriot, Yohann
    FUTURE ONCOLOGY, 2018, 14 (04) : 331 - 341
  • [39] Plasmacytoid urothelial carcinoma of the bladder
    Franchi, A.
    VIRCHOWS ARCHIV, 2010, 457 (02) : 130 - 131
  • [40] Chromium in urothelial carcinoma of the bladder
    Golabek, Tomasz
    Socha, Katarzyna
    Kudelski, Jacek
    Darewicz, Barbara
    Markiewicz-Zukowska, Renata
    Chlosta, Piotr
    Borawska, Maria
    ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE, 2017, 24 (04) : 602 - 605